1- Sobel J. Vulvovaginal candidosis. Lancet 2007 ; 369 :1961-71
2- Anderson MR et coll. Evaluation of vaginal complaints. JAMA 2004 ;291 :1368-79
3- Croxtall JD, Plosker GL. Sertaconazole : a review of its use in the management of superficial mycoses in dermatology and gynaecology. Drugs. 2009 ;69(3):339-59
4- Sobel JD et coll. Single oral dose fluconazol compared with conventional topical therapy of candida vaginitis. Am J Obstet Gynecol 1995 ; 172 :1263-8
5- Mendling W and the German Society for Gynecology and Obstetrics. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics. Mycoses. 2012 Jul ;55 Suppl 3:1-13.
6- Say J & Jacyntho Cl. Difficult –to- manage vaginitis. Clinical Obstet Gynecol 2005 ; 4 : 753-68
7- Ray D, Goswami R & coll. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis. J Infect. 2007 Oct ;55(4):374-7.
8- Trends in Candidal vaginitis Proceedings of thr Royal Society of Medicine 1977 : 70 : Suppl 4
Mise au point
La périménopause
Mise au point
La sclérose en plaques
Etude et Pratique
Appendicite aiguë de l’enfant : chirurgie ou antibiotiques ?
Mise au point
Le suivi des patients immunodéprimés en soins primaires